Exploring nurse–patient mutuality in inflammatory bowel disease: a multicenter cross-sectional study Daniele Napolitano, Silvia Cilluffo, Alessia Marini, Maura Lusignani BMC Nursing, 2026 BACKGROUND: Inflammatory bowel diseases (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), require long-term, multidisciplinary care. Within this model, the nurse-patient relationship is essential, yet little is known about mutuality-defined as shared trust, collaboration, and reciprocity. This study assessed nurse-patient mutuality in IBD using the Nurse-Patient Mutuality in Chronic Illness (NPM-CI) scale. METHODS: A multicenter, cross-sectional study was conducted in Italian IBD centers. Adult outpatients with confirmed IBD completed the NPM-CI patient version, a 20-item validated tool assessing three dimensions: developing and going beyond, being a point of reference, and deciding and sharing care. Descriptive statistics were used. RESULTS: Among 453 patients, 449 (94%) completed the NPM-CI. The mean total score was high (81.2 ± 13.3). UC patients reported higher scores than CD patients. The highest-rated items concerned respect for privacy and attention to well-being, while lower scores reflected limited emotional sharing and clarification of information from other professionals. CONCLUSIONS: This is the first study to evaluate nurse-patient mutuality in IBD using a validated tool. Findings highlight the central role of IBD nurses in building therapeutic relationships. Enhancing emotional communication and shared decision-making could further strengthen mutuality and improve care outcomes.
Predictors of self-care among informal caregivers of patients with inflammatory bowel disease: a cross-sectional study Daniele Napolitano Annals of Gastroenterology, 2026 Background: Informal caregivers of individuals with inflammatory bowel disease (IBD) face unpredictable responsibilities that may compromise their health. While caregiver burden and psychological distress are well-documented, little is known about caregivers' self-care practices and their determinants. Methods: A multicenter cross-sectional study was conducted across 9 Italian IBD Units between April and June 2024. Caregivers completed validated measures of self-care (Self-Care of Informal Caregivers Inventory), caregiver burden (Zarit Burden Interview), and psychological distress (Depression Anxiety Stress Scales-21). Logistic regression models were used to identify predictors of inadequate self-care behaviors. Results: A total of 229 caregivers were included (mean age 52.2±13.6 years; 59% women). Adequate self-care was high for routine behaviors such as daily hygiene (98.7%) and regular meals (87.8%), but low for emotionally and socially demanding behaviors, including professional counseling (18.3%), asking for assistance (12.2%), and accepting help (20.6%). Being unpartnered was associated with a higher likelihood of inadequate physical activity (odds ratio [OR] 2.38, 95% confidence interval [CI] 1.32-4.17). Higher anxiety was related to inadequate attention to bodily discomfort (OR 1.32, 95%CI 1.11-1.56), whereas higher caregiver burden and depression were associated with a lower likelihood of inadequate emotional wellbeing strategies (OR 0.97, 95%CI 0.95-0.99), and inadequate help-seeking (OR 0.80, 95%CI 0.68-0.93), respectively. Conclusions: Caregivers maintain basic health habits but show marked vulnerabilities in emotional and social self-care domains. Psychological distress and relational factors play a key role, underscoring the need for caregiver-centered interventions that promote emotional wellbeing, resilience, and help-seeking.
Optimizing healthcare through alignment and nurturing across cultures (OHANA) Cristina Pistacchio, Daniele Napolitano, Mariachiara Figura, Simone Amato, Alessio Lo Cascio, Eleonora Ribaudi, Noemi Giannetta, Sara Carrodano, Paola Arcadi, Alessandro Stievano Methodsx, 2026 The increasing cultural diversity of healthcare systems requires strategies that support effective communication and equitable care for patients from diverse cultural and linguistic backgrounds. Cultural concordance refers to situations in which patients and healthcare professionals share relevant cultural or linguistic characteristics that may facilitate communication and mutual understanding. In some healthcare organizations, this concept has been operationalized through organizational strategies aimed at aligning patients with healthcare professionals who share similar cultural or linguistic backgrounds. However, limited research has explored how these initiatives are experienced in clinical practice. The OHANA (Optimizing Healthcare through Alignment and Nurturing Across cultures) protocol was developed to investigate experiences of culturally concordant care within healthcare organizations that have implemented cultural concordance systems. This multicenter qualitative study, coordinated by the Fondazione Policlinico Universitario A. Gemelli IRCCS in Rome in collaboration with several Italian hospitals, will explore the perspectives of both healthcare professionals and patients. Data will be collected through semi-structured interviews and analyzed using inductive qualitative content analysis to identify themes related to communication, perceived benefits, and challenges associated with culturally concordant care. The findings are expected to inform strategies to support culturally responsive healthcare.
Adverse Childhood Experiences and Disease Activity Are Associated with Post-Traumatic Stress Symptoms in Crohn’s Disease Giorgia Spagnolo, Daniele Ferrarese, Federica Di Vincenzo, Jacopo Iaccarino, Marco Murgiano, Michele Vecchione, Guglielmo Sicilia, Daniele Napolitano, Antonio Maria D’Onofrio, Antonio Gasbarrini, Giovanni Camardese, Daniela Pia Rosaria Chieffo, Franco Scaldaferri Advances in Therapy, 2026 Crohn’s disease (CD) is a chronic inflammatory bowel disease associated with a substantial psychological burden, including post-traumatic stress symptoms (PTSS). However, PTSS do not develop in all patients, suggesting individual vulnerability factors. Adverse childhood experiences (ACEs) are a transdiagnostic risk factor for stress-related psychopathology and may influence psychological responses to chronic disease. We examined whether ACEs moderate the relationship between clinical disease activity and PTSS in patients with CD. In this cross-sectional study, outpatients with CD completed self-report measures assessing PTSS and ACEs. Clinical disease activity was assessed using the Harvey–Bradshaw Index. Data were analyzed using Pearson correlation coefficients and hierarchical moderated regression analyses. A total of 161 outpatients with CD were included. Clinically significant PTSS were observed in 32.1% of the sample. Disease activity was positively associated with PTSS (r = .33, p < .01), as was cumulative ACE exposure (r = .38, p < .01). In regression analyses, both disease activity (β = .22, p = .013) and ACEs (β = .35, p < .001) independently predicted PTSS, whereas disease duration was inversely associated (β = − .19, p = .047). A significant interaction between disease activity and ACEs emerged (ΔR2 = .034, p = .013), indicating a stronger association between disease activity and PTSS among patients with greater childhood adversity. Early-life adversity appears to increase vulnerability to PTSS in the context of active CD. ACE-informed assessments may help identify patients at higher psychological risk and guide trauma-informed clinical care.
Family Presence During Invasive Procedures or Resuscitation, Nurse Perception and Preparedness Questionnaire (FPDIP/R-NPPQ): A Validity and Reliability Study Davide Bartoli, Francesca Trotta, Mariachiara Figura, Marco Di Muzio, Daniele Napolitano, Marco Fatata, Gianluca Pucciarelli, Francesco Petrosino Nursing in Critical Care, 2026 Background Family presence during invasive procedures and resuscitation (FPDIP/R; FPDR) is increasingly advocated, yet no validated instrument assesses nurses' perceptions and preparedness including organisational readiness for implementation. Aim To develop and psychometrically validate the FPDIP/R‐NPPQ. Study Design A multicentre cross‐sectional survey was conducted in three Italian hospitals (April–July 2024). Registered nurses ( N = 212) completed a study‐specific instrument initially comprising 52 items; psychometric analyses were performed on 37 Likert‐type items. We applied a two‐step strategy: exploratory factor analysis (EFA; parallel analysis, principal axis factoring, oblimin rotation, marker‐index screening) followed by confirmatory factor analysis (CFA) using robust maximum likelihood for ordinal/non‐normal data. Reliability was estimated via McDonald's ω . A grant from the Center of Excellence for Nursing Scholarship, Rome, March 2025, is funding this research. Results EFA supported a 19‐item, three‐factor solution explaining 57.47% of variance: (1) emotional value and relational benefits of family presence (5 items); (2) communication skills and structured management (6 items); and (3) operational support through a dedicated staff member (8 items). CFA confirmed good fit (RMSEA = 0.05, 90% CI 0.04–0.06; CFit = 0.36; CFI = 0.93; TLI = 0.92; SRMR = 0.07), with standardised loadings ranging 0.24–0.92 and ω = 0.82–0.87 across factors. Model refinement improved fit without permitting cross‐loadings, preserving construct distinctiveness while accounting for localised method effects. Conclusions The FPDIP/R‐NPPQ is a valid and reliable 19‐item, three‐factor instrument measuring nurses' readiness for family presence during invasive procedures and resuscitation. By distinguishing attitudes towards family presence, communication/management preparedness and organisational readiness (including the facilitator role), the tool enables services to identify implementation barriers and to plan targeted training and governance strategies prior to adopting FPDR/FPDIP policies. Relevance to Clinical Practice The FPDIP/R‐NPPQ supports clinical governance by providing actionable subscale profiles to guide implementation of FPDIP/R. It can be used to baseline readiness across units, identify specific training and protocol needs and inform organisational decisions such as the allocation of a trained family facilitator, thereby supporting safer and more standardised family presence practices during critical procedures.
Self-Efficacy as a Mediator Between Caregiver Burden, Health Literacy, and Contribution to Self-Care in Inflammatory Bowel Disease Daniele Napolitano, Mattia Bozzetti, Francesco Petrosino, Silvia Cilluffo, Francesca Trotta, Gianluca Pucciarelli, Davide Bartoli, Alessio Lo Cascio, Ercole Vellone Digestive Diseases and Sciences, 2026 Purpose Informal caregivers play a critical role in supporting Self-Care behaviors in patients with inflammatory bowel disease (IBD). However, the extent to which caregiver burden, health literacy, and Self-Efficacy predict their contribution to patient Self-Care remains unclear, and the potential mediating role of Self-Efficacy has not yet been established. Methods A multicenter cross-sectional study was conducted across nine Italian IBD centers. Caregivers completed validated instruments assessing burden (Zarit Burden Interview, score range 0–88; higher scores indicate greater burden), health literacy (Single Item Literacy Screener, 1–5; scores > 2 indicate inadequate literacy), Self-Efficacy (CSE-CSC, standardized 0–100; higher scores indicate greater confidence), and caregiver contribution to Self-Care (CC-SC-CII, standardized 0–100 across maintenance, monitoring, and management; higher scores indicate greater contribution). Structural equation modelling explored direct and indirect associations among study variables. Results Among 275 caregivers, the mean age was 51 years ( SD = 13); 160 (58%) were female and 115 (42%) male. Mean contribution scores were 54.99 ( SD = 25.62) for Self-Care Maintenance, 67.33 ( SD = 32.28) for Self-Care Monitoring, and 56.18 ( SD = 23.15) for Self-Care Management. Mean Self-Efficacy was 72.41 ( SD = 18.42). Self-Efficacy significantly predicted Self-Care Monitoring ( β = 0.34, p < 0.001) and Self-Care Management ( β = 0.42, p < 0.001), while burden showed modest but significant associations across domains. Health literacy demonstrated no significant effects, and no mediation pathways were identified. Conclusion Self-Efficacy emerged as a central determinant of caregiver contribution to patient Self-Care in IBD, particularly for Self-Care Monitoring and Self-Care Management behaviors. Interventions aimed at strengthening caregiver confidence and tailored to gender- and disease-specific needs may enhance the quality of caregiving and ultimately support better patient outcomes.
Caregiver Contribution to Self-Care in Adults with Inflammatory Bowel Disease: A Cross-Sectional Multicenter Study Daniele Napolitano, Alessio Lo Cascio, Mattia Bozzetti, Fabrizio Benedetti, Giulia Petruccini, Francesco Petrosino, Silvia Cilluffo, Francesca Trotta, Davide Bartoli, Ercole Vellone, Gianluca Pucciarelli Nursing Reports, 2026 Background/Objectives: Inflammatory bowel disease (IBD) requires sustained self-care, yet patients’ ability to manage daily treatment and symptoms is often shaped by the support provided by informal caregivers. Methods: Guided by the Middle-Range Theory of Self-Care of Chronic Illness, this multicentre cross-sectional study described caregivers’ contributions to self-care maintenance, monitoring, and management in IBD, and compared these contributions between caregivers of patients with Crohn’s disease (CD) and those of patients with ulcerative colitis (UC). Results: A convenience sample of 275 caregivers of adult outpatients with IBD was recruited across multiple Italian centres. Caregiver contribution was measured using the Caregiver Contribution to Self-Care of Chronic Illness Inventory, together with caregiver self-efficacy and selected sociodemographic and clinical variables. Caregivers reported substantial involvement across all self-care domains, with significantly higher contributions to self-care maintenance among caregivers of patients with CD than among those caring for patients with UC. Monitoring and management scores were similar across groups. Regression analyses indicated disease-specific patterns, with caregiver gender, education, employment status, and patient clinical characteristics showing differential associations with self-care domains. Conclusions: These findings underscore the central role of caregivers in supporting self-care in IBD and suggest that structured, caregiver-focused approaches embedded in routine clinical pathways may strengthen dyadic chronic illness management.
The Italian Organizational Culture and Readiness Scale for System-Wide Integration of EBP (OCRSIEP) Scale: Psychometric Adaptation of an Existing Scale Daniele Napolitano, Alessio Lo Cascio, Mattia Bozzetti, Felice Curcio, Simone Amato, Roberta Guardione, Alessandro Stievano, Pasquale Iozzo, Daniela D'Angelo, Ippolito Notarnicola, Daniela Tartaglini, Dhurata Ivziku Worldviews on Evidence Based Nursing, 2026 Background Organizational culture and readiness are critical determinants of evidence‐based practice (EBP) implementation. The Organizational Culture and Readiness Scale for System‐Wide Integration of EBP (OCRSIEP), developed within the ARCC framework, is a validated tool to assess these dimensions, but no Italian version currently exists. Aim To translate, culturally adapt, and psychometrically validate the OCRSIEP and its short form in Italian. Methods A validation study was conducted, using exploratory and confirmatory factor analyses to derive and test the underlying model, followed by reliability testing with multiple indices and measurement invariance analyses. Results Data were collected from 405 Italian nurses. Factor analyses supported a 19‐item, six‐factor structure explaining 59.5% of the variance, with a second‐order factor indicating an overarching construct. The three‐item short form showed strong model fit and explained 67% of the variance. Subscales demonstrated acceptable‐to‐excellent reliability, and partial scalar invariance was established across public and private facilities. Linking Evidence to Action The Italian OCRSIEP scales are valid and reliable tools to assess organizational readiness for EBP implementation. They can guide leaders, educators, and researchers in monitoring, benchmarking, and advancing EBP–oriented system transformation within the Italian healthcare context.
A Longitudinal Mediation Analysis of Quality of Life After Metabolic and Bariatric Surgery Maria Rosaria Magurano, Daniele Napolitano, Mattia Bozzetti, Alessio Lo Cascio, Mauro Parozzi, Eleonora Ribaudi, Emanuela Rellini, Laura Antonella Fernandez Tayupant, Angela Gonsalez del Castillo, Sara Morales Palomares, Francesco Greco, Piero Giustacchini, Luigi Ciccoritti, Geltrude Mingrone, Caterina Guidone, Amerigo Iaconelli, Daniela Pia Rosaria Chieffo, Marco Raffaelli Obesity Science and Practice, 2026 Background and Aim Severe obesity is associated with physical comorbidity and impaired health‐related quality of life (HRQoL). Although metabolic and bariatric surgery (MBS) is generally associated with improvements in HRQoL and mental health, inter‐individual variability is substantial, and the functional mechanisms through which preoperative psychological distress may influence postoperative HRQoL trajectories are incompletely characterized. To provide a clearer mechanistic framework, this study examined whether baseline depressive and anxiety symptoms predict 12‐month HRQoL and whether reductions in functional psychosocial impairment mediate these improvements. Methods Single‐center longitudinal cohort of adults with severe obesity undergoing metabolic and bariatric surgery. Assessments at baseline (T0) and 12 months (T1) included the Patient Health Questionnaire–9 (PHQ‐9), Generalized Anxiety Disorder–7 (GAD‐7), Clinical Impairment Assessment (CIA), and the 36‐Item Short Form Health Survey (SF‐36). Bayesian multilevel mediation models (BMLM) adjusted for sociodemographic and clinical covariates were used. Results Participants ( n = 251; 76.9% women) showed significant reductions in depressive and anxiety symptoms, psychosocial impairment, and BMI from T0 to T1, alongside improvements in all SF‐36 domains ( p < 0.001). Mediation analyses revealed that reductions in psychosocial impairment significantly mediated the relationship between baseline depressive symptoms and HRQoL improvements, explaining up to 42% of the total effect. Anxiety symptoms showed weaker and less consistent mediation. Sensitivity analyses confirmed the robustness of findings across specifications. Conclusion MBS enhances HRQoL and reduces psychological distress. Psychosocial impairment mediates these benefits, especially for depressive symptoms. Integrating psychosocial assessment into pre‐ and postoperative care may help identify vulnerable patients and optimize long‐term outcomes.
The roles and professional competencies of clinical study coordinators and data managers in clinical trials: A systematic review Daniele Napolitano, Simone Amato, Elisabetta Creta, Francesca Profeta, Elisa Foscarini, Eleonora Ribaudi, Alessia Leonetti, Caterina Fanali, Gianluca Ianiro, Antonio Gasbarrini, Vincenzina Mora, , Fanali Caterina, Leonetti Alessia, Wlderk Giulia, Graziani Cristina, Capodrossi Anna, Teberino Maria Anna, Savini Roberta, Alberelli Maria Adele, Cala’ Palmarino Francesca, Leonti Gabriela, Murdolo Marina, Vetrone Maria Amelia, Zavarella Maria Antonietta, Creta Elisabetta, Foscarini Elisa, Profeta Francesca, Turchini Laura, Amatucci Valeria, Schiavoni Elisa, Durini Eleonora, Giordano Luciana Clinical Trials, 2026
Filgotinib effectiveness and safety as second or third-line therapy in patients with ulcerative colitis: data from a real-world study Antonio Tursi, Giammarco Mocci, Francesco Costa, Linda Ceccarelli, Edoardo Savarino, Caterina De Barba, Caterina Mucherino, Elvira D’Antonio, Laura Montesano, Manuela Marzo, Franco Scaldaferri, Daniele Napolitano, Daniela Pugliese, Antonietta Gerarda Gravina, Raffaele Pellegrino, Rocco Spagnuolo, Francesco Luzza, Antonio Cuomo, Laura Donnarumma, Giovanni Maconi, Giovanni Cataletti, Lorenzo Bertani, Giorgia Bodini, Andrea Pasta, Simona Piergallini, Mariaelena Serio, Antonella Scarcelli, Pietro Capone, Fabio Cortellini, Stefano Rodino, Ladislava Sebkova, Giuliana Vespere, Silvia Sedda, Vittorio D’Onofrio, Leonardo De Luca, Federica Gaiani, Stefano Kayali, Cristiano Pagnini, Maria Giovanna Graziani, Maria Carla Di Paolo, Leonardo Allegretta, Alessia Immacolata Cazzato, Stefano Scorza, Antonio Ferronato, Davide Giuseppe Ribaldone, Giovanni Aragona, Patrizia Perazzo, Giacomo Forti, Michela Di Fonzo, Federico Iacopini, Roberta Pica, Claudio Cassieri, Francesca Maria Onidi, Paolo Usai Satta, Walter Elisei, Marcello Picchio, Alfredo Papa Intestinal Research, 2026
Promoting Self-Care in Individuals with Inflammatory BowDisease: A Scoping Review Ilaria Milani, Daniele Napolitano, Monica Petralito, Stefano Romano Capatti, Elena Gennari, Simone Amato, Viviana Di Cosimo, Giulia Petruccini, Nicoletta Orgiana, Mattia Bozzetti, Alessio Lo Cascio, Rosario Caruso Journal of Gastrointestinal and Liver Diseases, 2026
Health Literacy in Parkinson Disease: A Scoping Review Monica Petralito, Ilaria Milani, Stefano Romano Capatti, Naomi Tagliani, Daniele Napolitano, Chiara Tedesco, Silvia Cilluffo, Stefano Terzoni, Maura Lusignani, Vincente Bernalte-Martì, Gianluca Pucciarelli, Rosario Caruso Journal of Neuroscience Nursing Journal of the American Association of Neuroscience Nurses, 2026
Italian EBP Implementation Scales: A Psychometric Validation Study Mattia Bozzetti, Alessio Lo Cascio, Daniele Napolitano, Felice Curcio, Simone Amato, Roberta Guardione, Rosario Caruso, Ippolito Notarnicola, Cesar Ivan Aviles Gonzalez, Francesca Reato, Daniela D'Angelo, Daniela Tartaglini, Dhurata Ivziku Worldviews on Evidence Based Nursing, 2026
Comparative Effectiveness and Safety of Tofacitinib, Filgotinib, and Upadacitinib in Ulcerative Colitis: A Multicenter Real-World Cohort Study Antonio Tursi, Andrea Pasta, Walter Elisei, Brigida Barberio, Giammarco Mocci, Edoardo V. Savarino, Caterina de Barba, Giovanni Maconi, Giovanni Cataletti, Franco Scaldaferri, Daniele Napolitano, Francesco Costa, Linda Ceccarelli, Manuela Marzo, Rita Monterubbianesi, Michela di Fonzo, Giovanni Lombardi, Marta Patturelli, Davide Giuseppe Ribaldone, Lorenzo Bertani, Stefano Rodino’, Ladislava Sebkova, Giorgia Bodini, Giuseppe Pranzo, Mariaelena Serio, Antonella Scarcelli, Ileana Luppino, Antonio Ferronato, Rocco Spagnuolo, Francesco Luzza, Domenico Morano, Antonietta Gerarda Gravina, Raffaele Pellegrino, Giuliana Vespere, Silvia Sedda, Leonardo Allegretta, Libera Fanigliulo, Laurino Grossi, Fabio Cortellini, Giacomo Forti, Viviana Neve, Simona Piergallini, Patrizio Scarozza, Girolamo Bevevino, Federico Iacopini, Pietro Capone, Federica Gaiani, Stefano Kayali, Caterina Mucherino, Elvira D’antonio, Berardino D’ascoli, Raffaele Colucci, Francesco Bachetti, Gian Marco Giorgetti, Valeria Clemente, Cristiano Pagnini, Antonio Cuomo, Laura Donnarumma, Francesca Maria Onidi, Paolo Usai Satta, Marcello Picchio, Alfredo Papa, Italian Network for Inflammatory Bowel Diseases (IN-IBD), Greta Lorenzon, Fabiana Zingone, Davide Checchin, Carla Felice, Gabrio Bassotti, Elisabetta Antonelli, Costantino Zampaletta, Giulia Rocco, Carlotta Sacchi, Maria Giovanna Graziani, Maria Carla Di Paolo, Roberta Pica, Maddalena Zippi, Andrea Cocco, Claudio Cassieri, Roberto Lorenzetti, Giulia Zerboni, Serafina Fiorella, Vittorio D’Onofrio, Laura Montesano, Guido Daniele Villani, Nicola Della Valle, Paolo Tonti, Alessia Immacolata Cazzato, Stefano Scorza, Giuseppina Grasso, Domenico Catarella, Dario D’Agostino, Elisabetta Di Bartolo Advances in Therapy, 2026
Upadacitinib’s Effectiveness and Safety as a Second- or Third-Line Therapy in Patients with Ulcerative Colitis: Data from a Real-World Study Giammarco Mocci, Antonio Tursi, Franco Scaldaferri, Daniele Napolitano, Daniela Pugliese, Giovanni Maconi, Giovanni Cataletti, Roberta Pica, Claudio Cassieri, Edoardo Vincenzo Savarino, Caterina De Barba, Francesco Costa, Linda Ceccarelli, Manuela Marzo, Walter Elisei, Rita Monterubbianesi, Roberto Faggiani, Giovanni Lombardi, Marta Patturelli, Davide Giuseppe Ribaldone, Lorenzo Bertani, Stefano Rodinò, Ladislava Sebkova, Giorgia Bodini, Andrea Pasta, Giuseppe Pranzo, Mariaelena Serio, Antonella Scarcelli, Ileana Luppino, Antonio Ferronato, Rocco Spagnuolo, Francesco Luzza, Antonietta Gerarda Gravina, Raffaele Pellegrino, Giuliana Vespere, Silvia Sedda, Vittorio D’Onofrio, Leonardo De Luca, Leonardo Allegretta, Alessia Immacolata Cazzato, Libera Fanigliuolo, Laurino Grossi, Fabio Cortellini, Giacomo Forti, Paolo Tonti, Viviana Neve, Simona Piergallini, Michela Di Fonzo, Federico Iacopini, Pietro Capone, Federica Gaiani, Stefano Kayali, Caterina Mucherino, Elvira D’Antonio, Laura Montesano, Andrea Cocco, Berardino D’Ascoli, Raffaele Colucci, Francesco Bachetti, Giorgia Orrù, Francesca Maria Onidi, Paolo Usai Satta, Marcello Picchio, Alfredo Papa Journal of Clinical Medicine, 2025
Definition of Skills and Roles of the Digestive Endoscopy Nurse Daniele Napolitano, Maria Luigia Candela, Mirko Gaggiotti, Laura Turchini, Gabri Bertaglia, Angela Nicoletta Minenna, Monia Valdinoci, Teresa Iannone, Nazario Munno, Giorgio Iori, Antonella Giaquinto, Alessandra Guarini, Giulio Petrocelli, Angelo Zullo Gastroenterology Nursing, 2025
The role of resilience in mitigating depression and anxiety in patients with inflammatory bowel diseases Daniele Ferrarese, Michele Vecchione, Giorgia Spagnolo, Antonio Mirijello, Federica Di Vincenzo, Daniela Belella, Giovanni Camardese, Antonio Maria D'Onofrio, Vincenzina Mora, Daniele Napolitano, Giovanni Cammarota, Franco Scaldaferri, Daniela Pia Rosaria Chieffo, Antonio Gasbarrini, Tommaso Dionisi, Giovanni Addolorato Journal of Psychosomatic Research, 2025
Impact of Psychopathology and Gut Microbiota on Disease Progression in Ulcerative Colitis: A Five-Year Follow-Up Study Franco Scaldaferri, Antonio Maria D’Onofrio, Elena Chiera, Adrian Gomez-Nguyen, Gaspare Filippo Ferrajoli, Federica Di Vincenzo, Valentina Petito, Lucrezia Laterza, Daniela Pugliese, Daniele Napolitano, Elisa Schiavoni, Giorgia Spagnolo, Daniele Ferrarese, Lorenza Putignani, Loris Riccardo Lopetuso, Giovanni Cammarota, Fabio Cominelli, Antonio Gasbarrini, Gabriele Sani, Giovanni Camardese Microorganisms, 2025
Adaptation of the European Crohn's Colitis Organisation quality of care standards to Italy: The Italian Group for the study of inflammatory bowel disease consensus Gionata Fiorino, Flavio Andrea Caprioli, Sara Onali, Fabio Salvatore Macaluso, Cristina Bezzio, Franco Armelao, Alessandro Armuzzi, Monia Baldoni, Giorgia Bodini, Fabiana Castiglione, Marco Daperno, Stefano Festa, Federica Furfaro, Paolo Gionchetti, Salvatore Leone, Gaetano Luglio, Monica Milla, Giammarco Mocci, Daniele Napolitano, Ambrogio Orlando, Enrica Previtali, Daniela Pugliese, Sara Renna, Antonio Rispo, Simone Saibeni, Gianluca Sampietro, Edoardo Savarino, Franco Scaldaferri, Rocco Spagnuolo, Angela Variola, Anna Viola, Angelo Viscido, Giovanna Vitale, Debora Zaetta, Fabiana Zingone, Agostino Colli, Massimo Claudio Fantini Digestive and Liver Disease, 2025
Long-Term Effectiveness and Safety of Ustekinumab in Crohn’s Disease: Results from a Large Real-Life Cohort Study Giammarco Mocci, Antonio Tursi, Franco Scaldaferri, Daniele Napolitano, Daniela Pugliese, Ivan Capobianco, Bianca Bartocci, Valentina Blasi, Edoardo V. Savarino, Daria Maniero, Carlo Redavid, Greta Lorenzon, Antonio Cuomo, Laura Donnarumma, Antonietta Gerarda Gravina, Raffaele Pellegrino, Giorgia Bodini, Andrea Pasta, Manuela Marzo, Mariaelena Serio, Antonella Scarcelli, Stefano Rodinò, Ladislava Sebkova, Giovanni Maconi, Giovanni Cataletti, Ileana Luppino, Davide Checchin, Antonio Ferronato, Federica Gaiani, Stefano Kayali, Carla Felice, Giuseppe Pranzo, Domenico Catarella, Dario D’Agostino, Elisabetta Di Bartolo, Giovanni Lombardi, Marta Patturelli, Emanuele Bendia, Laura Bolognini, Daniele Balducci, Claudia Quatraccioni, Francesco Martini, Caterina Mucherino, Elvira D’Antonio, Laura Montesano, Giuliana Vespere, Silvia Sedda, Vittorio D’Onofrio, Leonardo De Luca, Rocco Spagnuolo, Francesco Luzza, Libera Fanigliulo, Giulia Rocco, Carlotta Sacchi, Costantino Zampaletta, Laurino Grossi, Roberto Lorenzetti, Giovanni Aragona, Patrizia Perazzo, Giacomo Forti, Leonardo Allegretta, Alessia Immacolata Cazzato, Stefano Scorza, Fabio Cortellini, Pietro Capone, Guido Daniele Villani, Michela Di Fonzo, Federico Iacopini, Paolo Tonti, Viviana Neve, Raffaele Colucci, Walter Elisei, Rita Monterubbianesi, Roberto Faggiani, Roberta Pica, Cristiano Pagnini, Maria Giovanna Graziani, Maria Carla Di Paolo, Francesca Maria Onidi, Francesco Saba, Maria Pina Dore, Paolo Usai Satta, Marcello Picchio, Alfredo Papa Journal of Clinical Medicine, 2024
Changes in the intestinal microbiota in patients with a major depressive episode and ulcerative colitis Antonio M. D’ONOFRIO, Gaspare F. FERRAJOLI, Rosaria CALIA, Lorenza OGGIANO, Federica DI VINCENZO, Valentina PETITO, Eleonora MAGGIO, Daniele NAPOLITANO, Letizia MASI, Elisa SCHIAVONI, Caterina FANALI, Pierluigi PUCA, Laura TURCHINI, Loris R. LOPETUSO, Federica DEL CHIERICO, Lorenza PUTIGNANI, Gabriele SANI, Antonio GASBARRINI, Franco SCALDAFERRI, Giovanni CAMARDESE Minerva Psychiatry, 2024
Transition from intravenous to subcutaneous biological therapies in inflammatory bowel disease: An online survey of patients Daniele Napolitano, Carlo Romano Settanni, Laura Parisio, Nicoletta Orgiana, Andrea Poscia, Elisa Schiavoni, Laura Turchini, Alessio Lo Cascio, Francesco Germini, Elena Sblendorio, Alessandra Milani, Christopher Patteril, Lucrezia Laterza, Loris Riccardo Lopetuso, Daniela Pugliese, Alfredo Papa, Antonio Gasbarrini, Franco Scaldaferri Indian Journal of Gastroenterology, 2024
Switching from VEDOlizumab intravenous to subcutaneous formulation in ulcerative colitis patients in clinical remission: The SVEDO Study, an IG-IBD study Davide Giuseppe Ribaldone, Laura Parisio, Angela Variola, Fabrizio Bossa, Fabiana Castiglione, Manuela Marzo, Nicole Piazza, Annalisa Aratari, Edoardo Vincenzo Savarino, Giorgia Bodini, Mauro Mastronardi, Federica Micheli, Silvia Mazzuoli, Marta Ascolani, Chiara Viganò, Maria Cappello, Cristina Bezzio, Rachele Ciccocioppo, Giulia Scardino, Ennio Sarli, Daniela Pugliese, Franco Scaldaferri, Daniele Napolitano, Alessia Todeschini, Andrea Geccherle, Nicoletta Colaci, Maria Guerra, Monica Annese, Anna Testa, Anna Caiazzo, Francesco Simone Conforti, Stefano Festa, Greta Lorenzon, Antonella Marra, Ambra Magiotta, Flavia Baccini, Arnaldo Amato, Anxhela Poshnjari, Marta Vernero, Flavio Caprioli, Gian Paolo Caviglia Digestive and Liver Disease, 2024
Ustekinumab safety and effectiveness in patients with ulcerative colitis: results from a large real-life study Antonio Tursi, Giammarco Mocci, Franco Scaldaferri, Daniele Napolitano, Rossella Maresca, Daniela Pugliese, Gianluca Semprucci, Edoardo Savarino, Antonio Cuomo, Laura Donnarumma, Giorgia Bodini, Andrea Pasta, Giovanni Maconi, Giovanni Cataletti, Giuseppe Pranzo, Stefano Rodinò, Ladislava Sebkova, Francesco Costa, Antonio Ferronato, Federica Gaiani, Manuela Marzo, Ileana Luppino, Giulia Fabiano, Pietro Paese, Walter Elisei, Rita Monterubbianesi, Roberto Faggiani, Laurino Grossi, Mariaelena Serio, Antonella Scarcelli, Roberto Lorenzetti, Leonardo Allegretta, Stefania Chiri, Giuseppina Grasso, Elisabetta Antonelli, Gabrio Bassotti, Rocco Spagnuolo, Francesco Luzza, Libera Fanigliulo, Giulia Rocco, Carlotta Sacchi, Costantino Zampaletta, Chiara Rocchi, Laura Bolognini, Emanuele Bendia, Maria Antonia Bianco, Pietro Capone, Costantino Meucci, Raffaele Colucci, Paolo Tonti, Viviana Neve, Nicola Della Valle, Carla Felice, Roberta Pica, Andrea Cocco, Giacomo Forti, Francesca Maria Onidi, Paolo Usai Satta, Davide Checchin, Antonietta Gerarda Gravina, Raffaele Pellegrino, Marcello Picchio, Alfredo Papa Expert Opinion on Biological Therapy, 2024
Comparison of Performances of Adalimumab Biosimilars SB5, ABP501, GP2017, and MSB11022 in Treating Patients with Inflammatory Bowel Diseases: A Real-Life, Multicenter, Observational Study Antonio Tursi, Giammarco Mocci, Leonardo Allegretta, Giovanni Aragona, Maria Antonia Bianco, Raffaele Colucci, Antonio Cuomo, Nicola Della Valle, Antonio Ferronato, Giacomo Forti, Federica Gaiani, GianMarco Giorgetti, Maria Giovanna Graziani, Katia Lofano, Roberto Lorenzetti, Tiziana Larussa, Antonio Penna, Roberta Pica, Giuseppe Pranzo, Stefano Rodino’, Antonella Scarcelli, Costantino Zampaletta, Gabrio Bassotti, Alessia Immacolata Cazzato, Stefania Chiri, Valeria Clemente, Andrea Cocco, Gianluigi de’ Angelis, Laura Donnarumma, Roberto Faggiani, Camilla Graziosi, Marco Le Grazie, Francesco Luzza, Costantino Meucci, Rita Monterubbianesi, Cristiano Pagnini, Patrizia Perazzo, Marcello Picchio, Rodolfo Sacco, Ladislava Sebkova, Mariaelena Serio, Daniele Napolitano, Daniela Pugliese, Franco Scaldaferri, Elisa Schiavoni, Laura Turchini, Alessandro Armuzzi, Walter Elisei, Giovanni Maconi, Alfredo Papa Inflammatory Bowel Diseases, 2023
Assessment of Stress Levels using technological tools: A Review and Prospective Analysis of Heart Rate Variability and Sleep Quality Parameters Ceur Workshop Proceedings, 2023
Use of tofacitinib as first or second-line therapy is associated with better outcomes in patients with ulcerative colitis: data from a real-world study Antonio Tursi, Giammarco Mocci, Linda Cingolani, Edoardo Savarino, Roberta Pica, Andrea Cocco, Maddalena Zippi, Daniele Napolitano, Elisa Schiavoni, Daniela Pugliese, Franco Scaldaferri, Francesco Costa, Manuela Marzo, Mariaelena Serio, Antonella Scarcelli, Laura Bolognini, Emanuele Bendia, Giovanni Maconi, Rosanna Cannatelli, Simona Piergallini, Giorgia Bodini, Francesco Calabrese, Antonio Ferronato, Giuseppe Pranzo, Walter Elisei, Rita Monterubbianesi, Roberto Faggiani, Stefano Rodinò, Ladislava Sebkova, Laurino Grossi, Federica Gaiani, Gianluigi dè Angelis, Roberto Lorenzetti, Leonardo Allegretta, Alessia Immacolata Cazzato, Stefano Scorza, Nicola Della Valle, Rodolfo Sacco, Giacomo Forti, Raffaele Colucci, Paolo Tonti, Viviana Neve, Giulia Rocco, Carlotta Sacchi, Costantino Zampaletta, Cristiano Pagnini, Maria Giovanna Graziani, Maria Carla Di Paolo, Francesca Maria Onidi, Paolo Usai Satta, Marcello Picchio, Alfredo Papa Expert Opinion on Pharmacotherapy, 2023
Real-world efficacy and safety of vedolizumab in managing ulcerative colitis versus Crohn’s disease: results from an Italian multicenter study Giammarco Mocci, Antonio Tursi, Giovanni Maconi, Giovanni Cataletti, Beatrice Mantia, Mariaelena Serio, Antonella Scarcelli, Cristiano Pagnini, Maria Giovanna Graziani, Maria Carla Di Paolo, Giuseppe Pranzo, Ileana Luppino, Pietro Paese, Walter Elisei, Rita Monterubbianesi, Roberto Faggiani, Antonio Ferronato, Barbara Perini, Edoardo Savarino, Francesca Maria Onidi, Laura Binaghi, Paolo Usai Satta, Elisa Schiavoni, Daniele Napolitano, Franco Scaldaferri, Daniela Pugliese, Roberta Pica, Andrea Cocco, Maddalena Zippi, Stefano Rodino, Ladislava Sebkova, Giulia Rocco, Carlotta Sacchi, Costantino Zampaletta, Federica Gaiani, Gianluigi De Angelis, Stefano Kayali, Libera Fanigliulo, Roberto Lorenzetti, Leonardo Allegretta, Stefano Scorza, Antonio Cuomo, Laura Donnarumma, Nicola Della Valle, Rodolfo Sacco, Giacomo Forti, Elisabetta Antonelli, Gabrio Bassotti, Chiara Iannelli, Francesco Luzza, Giovanni Aragona, Patrizia Perazzo, Angelo Lauria, Simona Piergallini, Raffaele Colucci, Maria Antonia Bianco, Costantino Meucci, Gianmarco Giorgetti, Valeria Clemente, Serafina Fiorella, Antonio Penna, Antonio De Medici, Marcello Picchio, Alfredo Papa Expert Opinion on Biological Therapy, 2023
Knowledge of perianal Crohn's disease among nurses in an Italian tertiary centre Daniele Napolitano, Federica Cioffi, Giannina Marocchini, Tiziana Bernabei, Alessia Leonetti, Caterina Fanali, Nicoletta Orgiana, Valeria Amatucci, Antonio Gasbarrini, Carlo Ratto, Francesco Litta, Franco Scaldaferri Gastrointestinal Nursing, 2022
Impact of SARS-CoV-2 Infection on the Course of Inflammatory Bowel Disease in Patients Treated with Biological Therapeutic Agents: A Case-Control Study Alfredo Papa, Franco Scaldaferri, Marcello Covino, Antonio Tursi, Federica Furfaro, Giammarco Mocci, Loris Riccardo Lopetuso, Giovanni Maconi, Stefano Bibbò, Marcello Fiorani, Lucrezia Laterza, Irene Mignini, Daniele Napolitano, Laura Parisio, Marco Pizzoferrato, Giuseppe Privitera, Daniela Pugliese, Tommaso Schepis, Elisa Schiavoni, Carlo Romano Settanni, Lorenzo Maria Vetrone, Alessandro Armuzzi, Silvio Danese, Antonio Gasbarrini Biomedicines, 2022
The role of inflammatory bowel disease nurses for patients on biologic therapy during the COVID-19 pandemic Daniele Napolitano, Linda Galasso, Giuseppe Privitera, Giuseppe Morana, Arianna Bardelli, Rita Sinatora, Maria Francesca Onidi, Maria Teresa Lombardi, Nicoletta Orgiana, Valeria Amatucci, Martina Strazzeri, Elisa Schiavoni, Laura Turchini, Alessandra Guarini, Carlo Romano Settanni, Alessandro Armuzzi, Franco Scaldaferri Gastrointestinal Nursing, 2022
Innovative, complementary and alternative therapy in inflammatory bowel diseases: A broad 2020s update Letizia Masi, Cristina Ciuffini, Valentina Petito, Laura Francesca Pisani, Loris Riccardo Lopetuso, Cristina Graziani, Daniela Pugliese, Lucrezia Laterza, Pierluigi Puca, Federica Di Vincenzo, Marco Pizzoferrato, Daniele Napolitano, Laura Turchini, Valeria Amatucci, Elisa Schiavoni, Giuseppe Privitera, Laura Maria Minordi, Maria Chiara Mentella, Alfredo Papa, Alessandro Armuzzi, Antonio Gasbarrini, Franco Scaldaferri Frontiers in Gastroenterology, 2022
Comparison of performances of infliximab biosimilars CT-P13 versus SB2 in the treatment of inflammatory bowel diseases: a real-life multicenter, observational study in Italy Antonio Tursi, Giammarco Mocci, Leonardo Allegretta, Giovanni Aragona, Maria Antonia Bianco, Raffaele Colucci, Antonio Cuomo, Nicola Della Valle, Antonio Ferronato, Giacomo Forti, Federica Gaiani, Maria Giovanna Graziani, Roberto Lorenzetti, Francesco Luzza, Pietro Paese, Antonio Penna, Roberta Pica, Giuseppe Pranzo, Stefano Rodinò, Antonella Scarcelli, Costantino Zampaletta, Lorenzo Brozzi, Clelia Cicerone, Andrea Cocco, Gianluigi De’ Angelis, Laura Donnarumma, Serafina Fiorella, Chiara Iannelli, Tiziana Larussa, Marco Le Grazie, Ileana Luppino, Costantino Meucci, Roberto FaggianI, Cristiano Pagnini, Patrizia Perazzo, Kryssia Isabel Rodriguez-Castro, Rodolfo Sacco, Ladislava Sebkova, Mariaelena Serio, Alberta De Monti, Marcello Picchio, Daniele Napolitano, Elisa Schiavoni, Laura Turchini, Franco Scaldaferri, Daniela Pugliese, Luisa Guidi, Lucrezia Laterza, Giuseppe Privitera, Marco Pizzoferrato, Loris R. Lopetuso, Alessandro Armuzzi, Walter Elisei, Giovanni Maconi, Alfredo Papa Expert Opinion on Biological Therapy, 2022
Characterization of sarcopenia in an IBD population attending an Italian gastroenterology tertiary center Marco Pizzoferrato, Roberto de Sire, Fabio Ingravalle, Maria Chiara Mentella, Valentina Petito, Anna Maria Martone, Francesco Landi, Giacinto Abele Donato Miggiano, Maria Cristina Mele, Loris Riccardo Lopetuso, Elisa Schiavoni, Daniele Napolitano, Laura Turchini, Andrea Poscia, Nicola Nicolotti, Alfredo Papa, Alessandro Armuzzi, Franco Scaldaferri, Antonio Gasbarrini Nutrients, 2019
Nursing communication as a tool for patient satisfaction. A single hospital survey Anna Barilaro, Arianna Conidi, Sabrina Ligarò, Francesca Licata, Maria Anna Marinaro, Saverio Ventura, Anna Varano, Iolanda Zangari, Caterina Pagliuso, Raffaele Pagnotta, Pietro Garieri, Anna Papaleo, Laura Grande, Elena Manduci, Daniele Napolitano, Bianco Aida, Caterina De Filippo, Rocco Spagnuolo Open Nursing Journal, 2019
